Emerging Infectious Disease ISSN: 1080-6059

Vancomycin-Resistant Staphylococcus aureus, Michigan, USA, 2007

Jennie Finks

, Eden Wells, Teri Lee Dyke, Nasir Husain, Linda Plizga, Renuka Heddurshetti, Melinda Wilkins, James Rudrik, Jeffrey Hageman, Jean Patel, and Corinne Miller

Author affiliations: Michigan Department of Community Health, Lansing, Michigan, USA (J. Finks, E. Wells, T.L. Dyke, M. Wilkins, J. Rudrik, C. Miller); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Finks, J. Hageman, J. Patel); St. John Macomb-Oakland Hospital, Warren, Michigan, USA (N. Husain, L. Plizga); William Beaumont-Troy Hospital, Troy, Michigan, USA (R. Heddurshetti)

Main Article

Figure 2

Restriction enzyme (HindIII) digest of plasmids prepared from vancomycin-resistant Staphylococcus aureus (VRSA) isolates from 2 patients in Michigan, USA, 2007. Each lane is labeled with the VRSA isolate number; lane M, 1-kb molecular marker.

Figure 2. Restriction enzyme (HindIII) digest of plasmids prepared from vancomycin-resistant Staphylococcus aureus (VRSA) isolates from 2 patients in Michigan, USA, 2007. Each lane is labeled with the VRSA isolate number; lane M, 1-kb molecular marker.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.